BIM
RVMD icon

Breakwater Investment Management’s Revolution Medicines RVMD Stock Holding History

Breakwater Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44K Hold
13
– – ﹤0.01% 296
2026
Q1 		$1.26K Hold
13
– – ﹤0.01% 299
2025
Q4 		$1.04K Hold
13
– – ﹤0.01% 297
2025
Q3 		$608 Buy
+13
New +$509 ﹤0.01% 348

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Breakwater Investment Management's RVMD Position: Q2 2026 in Review

Breakwater Investment Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 13 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Breakwater Investment Management first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Breakwater Investment Management held 13 shares of Revolution Medicines worth $2.44K as of Q2 2026.
  • Breakwater Investment Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Breakwater Investment Management's portfolio in Q2 2026, its #296 holding.
  • Breakwater Investment Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Breakwater Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.